Amneal Pharmaceuticals Inc Class A (AMRX)

Income Tax Expense

$1.38M

Quarterly · Period ending: · USD

AMRX logo

AMRX Income Tax Expense

Latest reported$1.38M
AMRX Quarterly Income Tax ($1.55M → $1.38M)
High-resolution chart · PNG

AMRX income tax expense history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Amneal Pharmaceuticals Inc Class A Income Tax Expense — Quarterly (USD)
Period endingIncome Tax Expense (USD)
1,376,000
2,176,000
5,662,000
-23,355,000
16,101,000
12,868,000
5,423,000
3,666,000
3,618,000
6,156,000
9,883,000
-2,076,000
-23,000
668,000
-1,797,000
4,570,000
7,350,000
-3,461,000
4,140,000
4,049,000
2,648,000
359,000
1,485,000
144,000
2,186,000
-108,173,000
7,792,000
389,668,000
-5,701,000
-8,428,000
5,524,000
5,109,000
-12,416,000
364,000
-119,000
-738,000
1,852,000
1,003,000
1,550,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.